Calendar bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
2.37 USD -1.66% Intraday chart for bioAffinity Technologies, Inc. -14.75% +61.17%

Chart calendar bioAffinity Technologies, Inc.

31470f9822c1226.jk9FcJSBUl4Mu984jwWIVwGVx6Ek06Ylftp_zdg7Vrw.xhgBGtzpGgw9yOgO3l26I3vhs-Rm65BQSJEZleANENDJPDJG5cUZNU_4sA~fd0108e4c3bb23bda6d9c297538bb342

Upcoming events on bioAffinity Technologies, Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
17/05/2024 American Thoracic Society Conference
12/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
28/03/2025 Q4 2024 Earnings Release (Projected)

Past events on bioAffinity Technologies, Inc.

01/04/2024 07:19 pm Q4 2023 Earnings Release
15/11/2023 02:31 am Q3 2023 Earnings Release
12/10/2023 07:00 pm Dawson James Small Cap Growth Conference
20/09/2023 02:00 am Aquisition of Precision Pathology Laboratory Services, LLC by BioAffinity Technologies Inc Call
11/09/2023 09:30 am H.C. Wainwright Global Investment Conference
15/08/2023 02:33 am Q2 2023 Earnings Release
21/06/2023 RNA Therapeutics Symposium
06/06/2023 06:30 pm Annual General Meeting
15/05/2023 05:30 pm Q1 2023 Earnings Release
27/04/2023 Early Lung Cancer Detection Symposium
03/04/2023 06:30 pm Q4 2022 Earnings Call
01/04/2023 03:22 am Q4 2022 Earnings Release
14/11/2022 06:30 pm Q3 2022 Earnings Call
14/11/2022 06:00 pm Q3 2022 Earnings Release
16/10/2022 American College of Chest Physicians Conference

Annual results

Fiscal PeriodDecember 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


EBITDA
Released
Forecast
Spread
0,00


EBIT
Released
Forecast
Spread
0,00


Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


Net income
Million USD
Released
Forecast
Spread
-8,15


EPS
USD
Released
Forecast
Spread
-1,81


Announcement Date31/03/23

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIAF Stock
  4. Calendar bioAffinity Technologies, Inc.